Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Daily Security Review

Three CVEs, One Risk: Arbitrary Code Execution in Nessus Agent for Windows

16 Jun 2025

Description

In this episode, we dive deep into one of the most critical attack techniques in modern cyber warfare: privilege escalation—and how it recently hit center stage with three high-severity vulnerabilities discovered in Tenable’s Nessus Agent for Windows.We break down CVE-2025-36631, CVE-2025-36632, and CVE-2025-36633, which, when exploited, allow a non-administrative user to gain SYSTEM-level access, execute arbitrary code, delete critical files, or overwrite system content. These vulnerabilities, patched in version 10.8.5 of Nessus Agent, represent a textbook example of how privilege escalation paves the way for arbitrary code execution (ACE) and potential ransomware deployment.In the second half of the episode, we unpack: 🛠️ What privilege escalation is, including vertical and horizontal types 📊 Real-world exploitation paths on Windows systems 🔐 Why tools like BloodHound, winPEAS, and PowerUp are favorites among threat actors 📉 The security impact of misconfigured services, overprivileged accounts, and weak registry settings ✅ And most importantly: what your organization can do to detect, prevent, and mitigate privilege escalation attacks before they spiral out of controlWith privilege escalation playing a central role in everything from data breaches to ransomware infections, this episode is a must-listen for IT admins, security professionals, and anyone responsible for hardening their organization’s defenses.🔄 Don't forget to patch your Nessus Agents, enforce least privilege, and audit your environments regularly.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.